CellaVision AB (publ) (CLVSF)

20,24 0,00 (0,00 %) À partir de 09:30AM EDT. Marché ouvert.

CellaVision AB (publ)

Mobilvägen 12
Lund 223 62
Sweden
46 4 64 60 16 00
https://www.cellavision.com

Secteur(s): Healthcare
Secteur d’activité: Medical Devices
Employés à temps plein: 228

Dirigeants clés

Nom	Titre	Payer	Exercé	Année de naissance
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.	Founder & Director	285k	S.O.	1965
Mr. Simon Ostergaard	CEO & President	S.O.	S.O.	1971
Mr. Magnus Blixt	Chief Financial Officer	S.O.	S.O.	1966
Ms. Adele Horn	Corporate Communications & Investor Relations Manager	S.O.	S.O.	S.O.
Mr. Peter Wilson	Vice President of Global Marketing	S.O.	S.O.	1967
Mr. Urban Strindlov	Vice President of Global Sales	S.O.	S.O.	1964
Nina Wallander	Vice President of Human Resources	S.O.	S.O.	1974

Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en USD.

Description

CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides CellaVision DM1200 and CellaVision DM9600, designs to automate and simplify the process of performing blood and body fluid differentials; CellaVision DC-1, an analyzer to enable low-volume hematology labs to implement CellaVisions digital methodology for performing blood cell; and DIFF-Line that automates and digitizes the process of analyzing peripheral blood smears. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Proficiency Software, a web-based software designed to help laboratory managers assess, monitor, and promote staff competency in cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. Further, the company offers reagents to identify cell and tissue morphology, parasites, and bacteria in diagnosing various diseases; and instruments, including RAL SmearBox, RAL Stainbox, and RAL Stainer. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.

Gouvernance d’entreprise

L’ISS Governance QualityScore de CellaVision AB (publ) en date du 1 mai 2024 est 5. Les scores principaux sont Audit : 4; Société : 3; Droits des actionnaires : 1; Compensation : 8.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.